Expression of complement C5a receptor and the viability of 4T1 tumor cells following agonist–antagonist treatment
Background: Complement system is theoretically believed to halt the progression of tumor by the activity of C5a/CD88. Protein C5a is a potent pro.inflammatory mediator that activates the complement system by binding to its receptor. Objectives: The purpose of this study is to determine the expressi...
Main Authors: | Kosni, Nurneqman Nashreq, Ganti, Norhaifa, Mohd Noor, Mohd Hezmee, Abdul Razak, Intan Shameha, Md Ajat, Mohd Mokrish, Omar, Abdul Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
Medknow Publications
2016
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/54248/1/Expression%20of%20complement%20C5a%20receptor.pdf |
Similar Items
-
The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist
by: Xaria X. Li, et al.
Published: (2021-01-01) -
Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives
by: Cristina Giorgio, et al.
Published: (2021-04-01) -
Differential Contributions of the Complement Anaphylotoxin Receptors C5aR1 and C5aR2 to the Early Innate Immune Response against Staphylococcus aureus Infection
by: Sarah A. Horst, et al.
Published: (2015-10-01) -
Complement System Inhibitory Drugs in a Zebrafish (<i>Danio rerio</i>) Model: Computational Modeling
by: Dayanne Carla Fernandes, et al.
Published: (2023-09-01) -
Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice
by: Lan Li, et al.
Published: (2014-06-01)